Fu H - Search Results

1

HHEX suppresses advanced thyroid cancer by interacting with TLE3.

Xu Z, Feng Y, Yan Y, Jin H, Chen Y, Han Y, Huang S, Feng F, Fu H, Yin Y, Huang Y, Wang H, Cheng W. Xu Z, et al. Among authors: fu h. Mol Cell Endocrinol. 2023 Aug 20;574:111988. doi: 10.1016/j.mce.2023.111988. Epub 2023 Jun 10. Mol Cell Endocrinol. 2023. PMID: 37302518

2

Comparison of whole-body 18F-FDG SPECT and posttherapeutic 131I scintigraphy in the detection of metastatic thyroid cancer.

Wang H, Fu HL, Li JN, Zhou RJ, Hui Gu Z, Wu JC, Huang G. Wang H, et al. Among authors: fu hl. Clin Imaging. 2008 Jan-Feb;32(1):32-7. doi: 10.1016/j.clinimag.2007.07.010. Clin Imaging. 2008. PMID: 18164392

3

The role of single-photon emission computed tomography/computed tomography for precise localization of metastases in patients with differentiated thyroid cancer.

Wang H, Fu HL, Li JN, Zou RJ, Gu ZH, Wu JC. Wang H, et al. Among authors: fu hl. Clin Imaging. 2009 Jan-Feb;33(1):49-54. doi: 10.1016/j.clinimag.2008.06.024. Clin Imaging. 2009. PMID: 19135930

4

Evaluation of radionuclide cerebrospinal fluid scintigraphy as a guide in the management of patients with hydrocephalus.

Feng F, Fu HL, Li JN, Zhou RJ, Gui ZH, Wu JC, Wang H. Feng F, et al. Among authors: fu hl. Clin Imaging. 2009 Mar-Apr;33(2):85-9. doi: 10.1016/j.clinimag.2008.06.033. Clin Imaging. 2009. PMID: 19237049

5

The study of influence factors on (131)I treatment of differentiated thyroid carcinoma with lymph node metastases.

Ye ZY, Wang H, Fu HL, Li JN, Zou RJ, Gu ZH, Wu JC. Ye ZY, et al. Among authors: fu hl. Clin Imaging. 2009 May-Jun;33(3):221-5. doi: 10.1016/j.clinimag.2008.09.006. Clin Imaging. 2009. PMID: 19411029

6

Dedifferentiation of differentiated thyroid carcinoma cell line FTC-133 is enhanced by 131I pretreatment.

Feng F, Wang H, Fu H, Wu S, Ye Z, Chen S, Li J. Feng F, et al. Among authors: fu h. Nucl Med Biol. 2011 Oct;38(7):1053-8. doi: 10.1016/j.nucmedbio.2011.03.001. Epub 2011 Apr 21. Nucl Med Biol. 2011. PMID: 21982575

7

Re-induction of cell differentiation and (131)I uptake in dedifferentiated FTC-133 cell line by TSHR gene transfection.

Feng F, Wang H, Hou S, Fu H. Feng F, et al. Among authors: fu h. Nucl Med Biol. 2012 Nov;39(8):1261-5. doi: 10.1016/j.nucmedbio.2012.07.004. Epub 2012 Aug 14. Nucl Med Biol. 2012. PMID: 22898315

8

Low- or high-dose radioiodine remnant ablation for differentiated thyroid carcinoma: a meta-analysis.

Cheng W, Ma C, Fu H, Li J, Chen S, Wu S, Wang H. Cheng W, et al. Among authors: fu h. J Clin Endocrinol Metab. 2013 Apr;98(4):1353-60. doi: 10.1210/jc.2012-3682. Epub 2013 Feb 22. J Clin Endocrinol Metab. 2013. PMID: 23436920

9

Efficacy of lentiviral-mediated transfection of hTSHR in poorly differentiated thyroid carcinoma cell line.

Cheng W, Fu H, Feng F, Ma C, Li J, Chen S, Wang H. Cheng W, et al. Among authors: fu h. Nucl Med Biol. 2013 May;40(4):576-80. doi: 10.1016/j.nucmedbio.2012.12.004. Nucl Med Biol. 2013. PMID: 23618770

10

rhTSH-aided low-activity versus high-activity regimens of radioiodine in residual ablation for differentiated thyroid cancer: a meta-analysis.

Ma C, Tang L, Fu H, Li J, Wang H. Ma C, et al. Among authors: fu h. Nucl Med Commun. 2013 Dec;34(12):1150-6. doi: 10.1097/MNM.0b013e328365ac05. Nucl Med Commun. 2013. PMID: 24025918 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

7,670 results

Search Page